The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology
Abstract
\n Contains fulltext :\n 58492.pdf (Publisher’s version ) (Closed access)\n
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Self-citationIdentification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Forbes, C., & Collaborators, E. (1997) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1997.tb11433.x · Cited by 1,411
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
Stone, G. W., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Guagliumi, G., Stuckey, T., Turco, M., Carroll, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013404 · Cited by 1,277
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
Montalescot, G., Barragan, P., Wittenberg, O., Ecollan, P., Elhadad, S., Villain, P., Boulenc, J.-M., Morice, M.-C., Maillard, L., Pansiéri, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442503 · Cited by 1,186
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Bertrand, M. E., Rupprecht, H.-J., Urban, P., Gershlick, A. H., & Investigators, F. T. C. (2000) · Circulation · doi:10.1161/01.cir.102.6.624 · Cited by 1,010
Roncaglioni, M. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03539-x · Cited by 999
Boersma, E., Harrington, R. A., Moliterno, D. J., White, H., Théroux, P., Van de Werf, F., de Torbal, A., Armstrong, P. W., Wallentin, L. C., Wilcox, R. G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07442-1 · Cited by 991
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationAspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Self-citationPatrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Self-citationIdentification and Biological Activity of the Active Metabolite of Clopidogrel
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M., & Herbert, J. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614133 · Cited by 754
Brener, S. J., Barr, L. A., Burchenal, J. E. B., Katz, S., George, B. S., Jones, A. A., Cohen, E. D., Gainey, P. C., White, H. J., Cheek, H. B., et al. (1998) · Circulation · doi:10.1161/01.cir.98.8.734 · Cited by 722
Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105058 · Cited by 697
Hayden, M., Pignone, M., Phillips, C., & Mulrow, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00016 · Cited by 627
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006213222503 · Cited by 597
Self-citationPremature cardiovascular disease in chronic renal failure
Baigent, C., Burbury, K., & Wheeler, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02456-9 · Cited by 581
Taylor, D. W., Barnett, H. J., Haynes, R. B., Ferguson, G. G., Sackett, D. L., Thorpe, K. E., Simard, D., Silver, F. L., Hachinski, V., Clagett, G. P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05388-x · Cited by 530
JUULMOLLER, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92619-q · Cited by 517
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Stein, P. D., Alpert, J. S., Bussey, H. I., Dalen, J. E., & Turpie, A. G. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.220s · Cited by 496
Kassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 481
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453 · cited 1×
“The potential advantages of potent TP antagonists compared with low-dose aspirin relate to the recent discovery of aspirin-insensitive agonists of the platelet receptor, such as TXA2 derived from the COX-2 pathway(31) and the F2-isoprostane, 8-isoPGF2 , which is a product of free radical-catalyzed peroxidation of arac…”
BackgroundSelf-citationSanmuganathan, P. S., Ghahramani, P., Jackson, P. R., Wallis, E. J., & Ramsay, L. E. (2001) · Heart · doi:10.1136/heart.85.3.265 · Cited by 410
Nowak, J., Murray, J. J., Oates, J. A., & FitzGerald, G. A. (1987) · Circulation · doi:10.1161/01.cir.76.1.6 · Cited by 382
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13418 · Cited by 364
Self-citationChew, D. P., Bhatt, D. L., Sapp, S., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.201 · Cited by 359
García Rodríguez, L. A., Cattaruzzi, C., Troncon, M. G., & Agostinis, L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.33 · Cited by 335
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07370-1 · Cited by 326
Rocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., & Patrono, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112202999 · Cited by 317
Self-citationGarcía Rodríguez, L. A., & Hernández-Díaz, S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar146 · Cited by 236
Peter, K., Schwarz, M., Ylänne, J., Kohler, B., Moser, M., Nordt, T., Salbach, P., Kübler, W., & Bode, C. (1998) · Blood · doi:10.1182/blood.v92.9.3240 · Cited by 229
Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina
Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Di Gregorio, D., Bucciarelli, T., Davı̀, G., Cuccurullo, F., & Patrono, C. (2000) · Circulation · doi:10.1161/01.cir.102.9.1007 · Cited by 226
Self-citationAntithrombotic Therapy in Peripheral Arterial Occlusive Disease
Clagett, G. P., Graor, R. A., & Salzman, E. W. (1992) · Chest · doi:10.1378/chest.102.4_supplement.516s · Cited by 210
Grades of Recommendation for Antithrombotic Agents
Guyatt, G. H., Cook, D. J., Sackett, D. L., Eckman, M., & Pauker, S. (1998) · Chest · doi:10.1378/chest.114.5_supplement.441s · Cited by 206
Antithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Levine, H. J., Pauker, S. G., Eckman, M. H., & Daudelin, D. H. (1998) · Chest · doi:10.1378/chest.114.5_supplement.590s · Cited by 194
Cipollone, F., Patrignani, P., Greco, A., Panara, M. R., Padovano, R., Cuccurullo, F., Patrono, C., Rebuzzi, A. G., Liuzzo, G., Quaranta, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.4.1109 · Cited by 182
Self-citationGarcía Rodríguez, L. A., Varas, C., & Patrono, C. (2000) · Epidemiology · doi:10.1097/00001648-200007000-00004 · Cited by 177
Self-citationIncreased thromboxane biosynthesis in type IIa hypercholesterolemia.
Davì, G., Averna, M., Catalano, I., Barbagallo, C., Ganci, A., Notarbartolo, A., Ciabattoni, G., & Patrono, C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1792 · Cited by 166
Self-citationPlatelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets
Cicmil, M., Thomas, J. M., Leduc, M. M., Bon, C., & Gibbins, J. M. (2002) · Blood · doi:10.1182/blood.v99.1.137 · Cited by 152
Ray, W. A., Stein, C., & Halla, K. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00687-6 · Cited by 140
Acute coronary syndrome without ST elevation: implementation of new guidelines
Hamm, C. W., Bertrand, M. E., & Braunwald, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06585-0 · Cited by 124
Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease
Stafford, R. S. (2000) · Circulation · doi:10.1161/01.cir.101.10.1097 · Cited by 122
Cox, D. M., Smith, R., Quinn, M. J., Théroux, P., Crean, P., & Fitzgerald, D. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00919-0 · Cited by 119
The P2Y 12 receptor as a therapeutic target in cardiovascular disease
Storey, R. F. (2001) · Platelets · doi:10.1080/09537100120058739 · Cited by 118
Folco, G. C., Patrono, C., & Maclouf, J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615048 · Cited by 117
Self-citationMeade, T. W., & Brennan, P. J. (2000) · BMJ · doi:10.1136/bmj.321.7252.13 · Cited by 117
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
Stein, P. D., Dalen, J. E., Goldman, S., & Théroux, P. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.658s · Cited by 112
Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
Popma, J., Ohman, E., Weitz, J., Lincoff, A., Harrington, R. A., & Berger, P. (2001) · Chest · doi:10.1378/chest.119.1_suppl.321s · Cited by 104
de Schryver, E. L. L. M. (2000) · Cerebrovascular Diseases · doi:10.1159/000016044 · Cited by 103
Ticlopidine versus aspirin after myocardial infarction (stami) trial
Scrutinio, D., Cimminiello, C., Marubini, E., Pitzalis, M. V., Biase, M. D., & RIZZON, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01164-0 · Cited by 67
Cannon, C. P., & Turpie, A. G. G. (2003) · Circulation · doi:10.1161/01.cir.0000072246.69344.2d · Cited by 62
Mechanisms of platelet activation
Brass, L. F., & Stalker, T. J. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545276.005 · Cited by 50
Chen, Z.-M., & Second Chinese Cardiac Study (CCS-2) Collaborative Group (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700608 · Cited by 40
Cited by
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Guidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Self-citation
Metadata
- Authors
- Patrono, C.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 25
- Issue
- 2
- Pages
- 166-181
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2103688147
- Cited by
- 408
- References
- 66
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.